Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Management of Acute Respiratory Failure

Initial Assessment and Management

  • Perform immediate clinical evaluation focusing on work of breathing, mental status, and vital signs to determine severity of respiratory failure 1
  • Obtain arterial blood gas analysis to classify the type of respiratory failure (Type I: hypoxemic, Type II: hypercapnic) 1
  • Position the patient appropriately - semi-recumbent position (30-45° head elevation) if hemodynamically stable, or lateral position if unconscious to maintain airway patency 2
  • Document an individualized treatment plan at the start, including measures to be taken if initial therapy fails 1
  • Obtain chest radiography to identify potential causes or complications, but do not delay treatment in severe cases 1

Oxygen Therapy

  • Administer controlled oxygen therapy targeting saturation of 88-92% in all causes of acute hypercapnic respiratory failure 3, 1
  • Entrain oxygen as close to the patient as possible to optimize delivery 3
  • Monitor oxygen saturation continuously for at least 24 hours after initiating treatment 3, 4
  • Recheck arterial blood gases 1-2 hours after starting oxygen therapy to ensure adequate oxygenation without worsening hypercapnia 1

Non-Invasive Ventilation (NIV)

  • Initiate NIV when pH <7.35 and pCO2 >6.5 kPa persist despite optimal medical therapy, as this reduces mortality and need for intubation in appropriate patients 1
  • Consider NIV for patients with dyspnea and/or persistent hypoxemia despite oxygen therapy 2
  • Select appropriate interface (mask) based on patient comfort and facial anatomy, ensuring proper fit to minimize leaks 3, 5
  • Start with low pressures (e.g., IPAP 10-12 cmH2O, EPAP 4-5 cmH2O) and gradually increase as tolerated 5
  • Both pressure support and pressure control modes are effective; use only ventilators specifically designed for NIV 3
  • Measure arterial blood gases after 1-2 hours of NIV and again after 4-6 hours if the earlier sample showed little improvement 4
  • If no improvement in PaCO2 and pH after 4-6 hours despite optimal ventilator settings, consider discontinuing NIV and evaluate for invasive ventilation 4
  • Provide NIV for as many hours as possible during the first 24 hours, allowing breaks for medications, meals, and physiotherapy 5, 4

High-Flow Nasal Oxygen (HFNO)

  • Consider HFNO rather than NIV for management of acute hypoxemic respiratory failure, as it may be better tolerated 6
  • HFNO is also recommended over conventional oxygen therapy for postextubation acute hypoxemic respiratory failure 6

Invasive Mechanical Ventilation

  • Consider invasive ventilation when NIV fails as initial therapy 7
  • Consider invasive ventilation when patient has contraindications to NIV 3
  • Consider invasive ventilation when risk/benefit analysis favors better outcome with invasive ventilation 1
  • When using invasive ventilation, set appropriate positive end-expiratory pressure with tidal volumes of 6 mL/kg ideal body weight 2
  • Limit peak or plateau pressures to below 30 cmH2O to prevent barotrauma 2
  • Prefer spontaneous breathing modes when possible 2

Pharmacological Management

  • Administer nebulized bronchodilators during breaks from NIV, or via a nebulizer inserted into the ventilator tubing if the patient is NIV-dependent 3
  • Consider heated humidification if the patient reports mucosal dryness or if respiratory secretions are thick 3
  • Use sedation cautiously and only with close monitoring; if intubation is not intended should NIV fail, sedation/anxiolysis is indicated for symptom control 3
  • For agitated/distressed patients on NIV, consider intravenous morphine 2.5-5 mg (with or without benzodiazepine) to improve tolerance 3

Monitoring and Follow-up

  • Regularly assess respiratory rate, heart rate, blood pressure, level of consciousness, and patient comfort 1
  • Monitor for treatment failure indicators: deteriorating condition, worsening blood gases, development of new symptoms or complications, intolerance of ventilatory support 7
  • Check for common complications: pneumothorax, aspiration pneumonia, mask-related pressure sores, gastric distention 7
  • Perform spirometric testing and arterial blood gas analysis while breathing air before discharge for all patients treated with NIV for acute hypercapnic respiratory failure 4
  • Refer patients with spinal cord lesions, neuromuscular disease, chest wall deformity, or morbid obesity who develop acute hypercapnic respiratory failure to centers providing long-term ventilation at home 4

Organizational Aspects

  • Designate a specific area with trained staff for NIV delivery, with clear protocols for initiation and supervision 5
  • Patients with more severe acidosis (pH <7.30) should be managed in a higher dependency area such as HDU or ICU 5
  • Patients with respiratory failure from causes where NIV efficacy is not well established (pneumonia, ARDS, asthma) should only receive NIV in HDU or ICU settings with immediate intubation capability 5
  • Ensure proper infection control: reprocess reusable masks and exhalation valves, use bacterial filters, and clean ventilator surfaces between patients 5